A tuberculosis biomarker database: the key to novel TB diagnostics.
New diagnostic innovations for tuberculosis (TB), including point-of-care solutions, are critical to reach the goals of the End TB Strategy. However, despite decades of research, numerous reports on new biomarker candidates, and significant investment, no well-performing, simple and rapid TB diagnostic test is yet available on the market, and the search for accurate, non-DNA biomarkers remains a priority. To help overcome this 'biomarker pipeline problem', FIND and partners are working on the development of a well-curated and user-friendly TB biomarker database. The web-based database will enable the dynamic tracking of evidence surrounding biomarker candidates in relation to target product profiles (TPPs) for needed TB diagnostics. It will be able to accommodate raw datasets and facilitate the verification of promising biomarker candidates and the identification of novel biomarker combinations. As such, the database will simplify data and knowledge sharing, empower collaboration, help in the coordination of efforts and allocation of resources, streamline the verification and validation of biomarker candidates, and ultimately lead to an accelerated translation into clinically useful tools.
FIND, Chemin des Mines 9, CH-1202 Geneva, Switzerland.
Seda
S
Yerlikaya
FIND, Chemin des Mines 9, CH-1202 Geneva, Switzerland. Electronic address: tobias.broger@finddx.org.
Tobias
T
Broger
McGill International TB Centre, Research Institute of the McGill University Health Centre, Montreal, QC, Canada.
Emily
E
MacLean
McGill International TB Centre, Research Institute of the McGill University Health Centre, Montreal, QC, Canada; McGill Global Health Programs, McGill University, Montreal, QC, Canada.
Madhukar
M
Pai
FIND, Chemin des Mines 9, CH-1202 Geneva, Switzerland.
Claudia M
CM
Denkinger
D015415:Biomarkers; D016208:Databases, Factual; D006801:Humans; D014376:Tuberculosis / Q000175:diagnosis*
D015415:Biomarkers
Biomarkers; Database; Pipeline; Tuberculosis